Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Sylvia Herold, PhD, Matthias Kuhn, Uwe Platzbecker, MD, Stange Thoralf, Jörgen Radke, MD, Caroline Heiderich, Lange Thoralf, MD, Kerstin Gutsche, MD, Johannes Schetelig, Stefani Parmentier, MD, Brigitte Mohr, PhD, Markus Schaich, MD, Hubert Serve, Prof. Dr. med., Christian H. Brandts, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede

Blood (2012) 120 (21): 886.

https://doi.org/10.1182/blood.V120.21.886.886

Published: 2012

Journal Articles

Minimal Residual Disease (MRD) Based Preemptive 5–Azacytidine Treatment Can Prevent or Delay Imminent Relapse In Patients with High-Risk MDS or AML After Allogenic HSCT – Results of the “RELAZA” Trial

Uwe Platzbecker, Martin Wermke, Jörgen Radke, Alexander Kiani, Franzi Seltmann, Christoph Röllig, Malte von Bonin, Brigitte Mohr, Uta Oelschlägel, Johannes Schetelig, Gerhard Ehninger, Martin Bornhäuser, Christian Thiede

Blood (2010) 116 (21): 679.

https://doi.org/10.1182/blood.V116.21.679.679

Published: 2010

Journal Articles

Appearance of Mature 6-Sulfo LacNAc + Dendritic Cells In Early and Late Engraftment After Allogeneic Stem Cell Transplantation.

Sebastian Tuve, Konrad Mager, Rebekka Wehner, Felix Bahr, Uta Ölschlegel, Nona Shayegi, Jan Moritz Middeke, Conrad Heuchel, Christoph Röllig, Jörgen Radke, Martin Wermke, Uwe Platzbecker, Johannes Schetelig, Christian Thiede, Gerhard Ehninger, Prof., Martin Bornhaeuser, Marc Schmitz

Blood (2010) 116 (21): 3720.

https://doi.org/10.1182/blood.V116.21.3720.3720

Published: 2010

Journal Articles

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

Friedrich Stölzel, MD, Christoph Röllig, Michael Kramer, Brigitte Mohr, Uta Oelschlägel, Jörgen Radke, Christian Thiede, Martin Bornhaeuser, MD, Gerhard Ehninger, MD, Markus Schaich, MD

Blood (2010) 116 (21): 2154.

https://doi.org/10.1182/blood.V116.21.2154.2154

Published: 2010

Journal Articles

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Friedrich Stölzel, MD, Klaus Zoephel, Christoph Röllig, Jörgen Radke, Johannes Schetelig, Uwe Platzbecker, Martin Bornhaeuser, MD, Gerhard Ehninger, MD, Jörg Kotzerke, Markus Schaich, MD

Blood (2010) 116 (21): 2156.

https://doi.org/10.1182/blood.V116.21.2156.2156

Published: 2010

NARROW

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Minimal Residual Disease (MRD) Based Preemptive 5–Azacytidine Treatment Can Prevent or Delay Imminent Relapse In Patients with High-Risk MDS or AML After Allogenic HSCT – Results of the “RELAZA” Trial

Appearance of Mature 6-Sulfo LacNAc + Dendritic Cells In Early and Late Engraftment After Allogeneic Stem Cell Transplantation.

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Minimal Residual Disease (MRD) Based Preemptive 5–Azacytidine Treatment Can Prevent or Delay Imminent Relapse In Patients with High-Risk MDS or AML After Allogenic HSCT – Results of the “RELAZA” Trial

Appearance of Mature 6-Sulfo LacNAc + Dendritic Cells In Early and Late Engraftment After Allogeneic Stem Cell Transplantation.

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only